Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness

JAMA

Volumn 294, Issue 13, 2005, Pages 1625-1633

  Hill, James A ^a   Pauly, Daniel F ^a   Olitsky, Debra R ^a   Russell, Stuart ^b   O'Connor, Christopher M ^b   Patterson, Beth ^b   Elkayam, Uri ^c   Khan, Salman ^c   Stevenson, Lynne W ^d   Brooks, Kimberly ^d   Wagoner, Lynne ^e   Conway, Ginger ^e   Koelling, Todd ^f   Van Huysen, Carol ^f   Hare, Joshua ^g   Breton, Elayne ^g   Adams, Kirkwood F ^h   Glotzer, Jana ^h   Fonarow, Gregg ⁱ   Hamilton, Michele ⁱ   Sorg, Julie ⁱ   Drazner, Mark ^j   Hoffman, Shannon ^j   Miller, Leslie W ^k   Graziano, Judith A ^k   Berman, Mary Ellen ^k   Frantz, Robert ^l   Hartman, Karen ^l   Leier, Carl V ^m   Abraham, William T ^m   Yamokoski, Laura ^m   DiSalvo, Thomas G ⁿ   Camuso, Janice ⁿ   Gheorghiade, Mihai ^o   Fachet, Karen ^o   Heroux, Alain ^p   Soo, Jin Kim ^p   Warnica, J Wayne ^q   Grant, Jane ^q   Hasan, Mian ^r   Withrow, Lydia ^r   Young, James ^s   Gus, Barbara ^s   Butler, Javed ^t   Hawkins, Laurie ^t   Rayburn, Barry K ^u   Robinson, Jessica ^u   Piña, Ileana ^v   Shelby, Lori ^v   Rogers, Joseph ^w   Craddock, Heidi ^w   Tonkon, Melvin ^x   Miller, Shane ^x   DeMarco, Teresa ^y   Lau, Debra ^y   Johnson, Maryl ^z   Ark, Cassondra Vander ^z   more..

^a UNIVERSITY OF FLORIDA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c LAC USC   (Chad)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF CINCINNATI   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g Johns Hopkins   (United States)

^h UNIVERSITY OF NORTH CAROLINA   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UT Southwestern   (United States)

^k UNIVERSITY OF MINNESOTA   (United States)

^l MAYO CLINIC   (United States)

^m OHIO STATE UNIVERSITY   (United States)

ⁿ Mass General

^o Northwestern Unversity   (United States)

^p RUSH UNIVERSITY MEDICAL CENTER   (United States)

^q UNIVERSITY OF CALGARY   (Canada)

^r UNIVERSITY OF KENTUCKY   (United States)

^s LERNER RESEARCH INSTITUTE   (United States)

^t VANDERBILT UNIVERSITY   (United States)

^u University of Alabama   (United States)

^v UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^w UNIVERSITY OF WASHINGTON   (United States)

^x Anaheim Heart and Research Institute   (United States)

^y UNIVERSITY OF CALIFORNIA   (United States)

^z University of Wisconsin   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCERYL TRINITRATE; NESIRITIDE; NITROPRUSSIDE SODIUM; SODIUM; VASODILATOR AGENT;

ADULT; ARTERY CATHETERIZATION; ARTICLE; CENTRAL VENOUS PRESSURE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; EDEMA; EXERCISE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT ATRIUM PRESSURE; HOSPITALIZATION; HUMAN; LUNG CAPILLARY PRESSURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PULMONARY ARTERY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SODIUM BLOOD LEVEL; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL;

EID: 26044460566     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.294.13.1625     Document Type: Article

References (52)

1. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.N Engl J Med. 1991;325:303-310.
2. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
3. Pitt B, Zannad F, Remme WJ, et al; Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341:709-717.
4. Packer M, Coats AJ, Fowler MB, et al; Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651-1658.
5. Fonarow GC, Adams KF, Abraham WT, Yancy CW, Boscardin WJ; ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293:572-580.
6. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290:2581-2587.
7. Rose EA, Gelijns AC, Moskowitz AJ, et al; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.
8. Stevenson LW, Tillisch JH. Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure. Circulation. 1986;74:1303-1308.
9. Stevenson LW, Brunken RC, Belil D, et al. Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. J Am Coll Cardiol. 1990;15:174-180.
10. Stevenson LW, Sietsema K, Tillisch JH, et al. Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failure. Circulation. 1990;81:78-85.
11. Steimle AE, Stevenson LW, Chelimsky-Fallick C, et al. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Circulation. 1997;96:1165-1172.
12. Hamilton MA, Stevenson LW, Child JS, Moriguchi JD, Walden J, Woo M. Sustained reduction in valvular regurgitation and atrial volumes with tailored vasodilator therapy in advanced congestive heart failure secondary to dilated (ischemic or idiopathic) cardiomyopathy. Am J Cardiol. 1991;67:259-263.
13. Rosario LB, Stevenson LW, Solomon SD, Lee RT, Reimold SC. The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size. J Am Coll Cardiol. 1998;32:1819-1824.
14. Fonarow GC, Stevenson LW, Walden JA, et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol. 1997;30:725-732.
15. Fonarow GC, Chelimsky-Fallick C, Stevenson LW, et al. Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial. J Am Coll Cardiol. 1992;19:842-850.
16. Connors AF Jr, Speroff T, Dawson NV, et al; SUPPORT Investigators. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA. 1996;276:889-897.
17. Dalen JE, Bone RC. Is it time to pull the pulmonary artery catheter? JAMA. 1996;276:916-918.
18. Shah MR, O'Connor CM, Sopko G, Hasselblad V, Califf RM, Stevenson LW. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale. Am Heart J. 2001;141:528-535.
19. Bittner V, Weiner DH, Yusuf S, et al; SOLVD Investigators. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA. 1993;270:1702-1707.
20. Rector TS, Tschumperlin LK, Kubo SH, et al. Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail. 1995;1:201-206.
21. Lewis EF, Johnson PA, Johnson W, Collins C, Griffin L, Stevenson LW. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant. 2001;20:1016-1024.
22. Lan K, Gordon K, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika. 1983;70:659-663.
23. Davidian M, Tsiatis A, Leon S. Semi-parametric estimation of treatment effect in a pretest-posttest study with missing data. Stat Sci. 2005;20:261-301.
24. Gore JM, Goldberg RJ, Spodick DH, Alpert JS, Dalen JE. A community-wide assessment of the use of pulmonary artery catheters in patients with acute myocardial infarction. Chest. 1987;92:721-727.
25. Zion MM, Balkin J, Rosenmann D, et al; SPRINT Study Group. Use of pulmonary artery catheters in patients with acute myocardial infarction: analysis of experience in 5,841 patients in the SPRINT Registry. Chest. 1990;98:1331-1335.
26. Stevenson LW, Tillisch JH, Hamilton M, et al. Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol. 1990;66:1348-1354.
27. Campana C, Gavazzi A, Berzuini C, et al. Predictors of prognosis in patients awaiting heart transplantation. J Heart Lung Transplant. 1993;12:756-765.
28. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660-2667.
29. Kaye DM, Lambert GW, Lefkovits J, Morris M, Jennings G, Esler MD. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol. 1994;23:570-578.
30. Komuro I, Katoh Y, Kaida T, et al. Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat cardiac myocytes: possible role of protein kinase C activation. J Biol Chem. 1991;266:1265-1268.
31. Leri A, Claudio PP, Li Q, et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local reninangiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest. 1998;101:1326-1342.
32. Sandham JD, Hull RD, Brant RF, et al; Canadian Critical Care Clinical Trials Group. A randomized controlled trial of the use of pulmonary-artery catheters in highrisk surgical patients. N Engl J Med. 2003;348:5-14.
33. Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA. 2005;293:1900-1905.
34. Kovick RB, Tillisch JH, Berens SC, Bramowitz AD, Shine KI. Vasodilator therapy for chronic left ventricular failure. Circulation. 1976;53:322-328.
35. Pierpont GL. Medical management of terminal cardiomyopathy. J Heart Transplant. 1982;2:18-27.
36. Stevenson LW, Dracup KA, Tillisch JH. Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation. Am J Cardiol. 1989;63:461-464.
37. Lucas C, Johnson W, Hamilton MA, et al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J. 2000;140:840-847.
38. Stevenson LW, Steimle AE, Fonarow G, et al. Improvement in exercise capacity of candidates awaiting heart transplantation. J Am Coll Cardiol. 1995;25:163-170.
39. Chomsky DB, Lang CC, Rayos G, Wilson JR. Treatment of subclinical fluid retention in patients with symptomatic heart failure: effect on exercise performance. J Heart Lung Transplant. 1997;16:846-853.
40. Drazner MH, Hamilton MA, Fonarow G, Creaser J, Flavell C, Stevenson LW. Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. J Heart Lung Transplant. 1999;18:1126-1132.
41. Weinfeld MS, Chertow GM, Stevenson LW. Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J. 1999;138:285-290.
42. Butler J, Forman DE, Abraham WT, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J. 2004;147:331-338.
43. Bender JS, Smith-Meek MA, Jones CE. Routine pulmonary artery catheterization does not reduce morbidity and mortality of elective vascular surgery: results of a prospective, randomized trial. Ann Surg. 1997;226:229-236.
44. Berlauk JF, Abrams JH, Gilmour IJ, O'Connor SR, Knighton DR, Cerra FB. Preoperative optimization of cardiovascular hemodynamics improves outcome in peripheral vascular surgery: a prospective, randomized clinical trial. Ann Surg. 1991;214:289-297.
45. Valentine RJ, Duke ML, Inman MH, et al. Effectiveness of pulmonary artery catheters in aortic surgery: a randomized trial. J Vasc Surg. 1998;27:203-211.
46. Bonazzi M, Gentile F, Biasi GM, et al. Impact of perioperative haemodynamic monitoring on cardiac morbidity after major vascular surgery in low risk patients: a randomised pilot trial. Eur J Vasc Endovasc Surg. 2002;23:445-451.
47. Shah MR, Stevenson LW, Binanay C, O'Connor CM, Sopko G, Califf RM. The impact of the pulmonary artery catheter on critically ill populations: a meta-analysis of randomized clinical trials. JAMA. In press.
48. Harvey S, Harrison DA, Singer M, et al. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. Lancet. 2005;366:472-477.
49. Abraham WT, Fisher WG, Smith AL, et al; MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845-1853.
50. Havranek EP, McGovern KM, Weinberger J, Brocato A, Lowes BD, Abraham WT. Patient preferences for heart failure treatment: utilities are valid measures of health-related quality of life in heart failure. J Card Fail. 1999;5:85-91.
51. Torrance GW. Measurement of health state utilities for economic appraisal: a review. J Health Econ. 1986;5:1-30.
52. Trottier SJ, Taylor RW. Physicians' attitudes toward and knowledge of the pulmonary artery catheter: Society of Critical Care Medicine membership survey. New Horiz. 1997;5:201-206.